News & Events

Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.

Colin Mackay, CEO of Symbiosis

A positive end to a positive year at Symbiosis

It may feel like only yesterday we were planning for 2016, but here we are at the end of another successful year. While the last 12 months have seemingly gone in a flash, it’s been another encouraging year at Symbiosis Pharmaceutical Services.With the support of our clients, staff, suppliers and partners, I’m pleased to say it’s been another steady year of growth… Read More

Qualified Person Release

The Good CMO Guide – What should small biotechs look for when outsourcing clinical trial manufacturing?

What kind of relationship are you looking for? It’s the first question that should be on the minds of biotech companies once the decision to outsource clinical trial manufacturing of parenterals to a CMO has been made. Is it a transactional relationship? One where a service is sourced and swiftly delivered without much in the way of long-term planning or on-going work… Read More

Q&A: Parenteral Outsourcing Trends

Our own Colin MacKay, CEO of Symbiosis Pharmaceutical Services, was recently invited to participate in a roundtable discussion assessing the trends driving parenteral manufacturing for an article for Contract Pharma.The resulting article explores the trends that are fuelling the demand for parenteral manufacturing, the changing structure of the CMO industry and the impact on biotech and small pharma companies needing to outsource… Read More

Q&A: Biotech growth driving ‘surge in demand’

Here at Symbiosis Pharmaceutical Services we’re preparing for increasing growth in the outsourcing sector following an investment at our sterile filling facility and the appointment of Dr. Tom Scullion, US Business Development Manager.Having joined the team to support increased demand for our sterile filling services from biotechs, Tom was recently invited to talk about his role here at Symbiosis and his insight into where… Read More

A review of BIO International Convention 2016

The dust has settled and it’s business as usual here in Stirling after BIO International Convention in San Francisco but we just wanted to take a moment to reflect on our main take-homes from the event…There is certainly a feeling of general buoyancy and positivity in the industry. It is clear that the investment community continues to see the biotech sector as… Read More

Biotech Boom Fuels Parenteral Market

Colin MacKay, CEO of Symbiosis Pharmaceutical Services assesses the trends driving parenteral manufacturing in this guest blog as featured on Contract Pharma.“There are a number of factors that are influencing the growing demand for aseptically-processed parenteral products. The continued growth of the biotech sector and increased funding available are major drivers, while mergers and acquisitions within the contract manufacturing organization (CMO) space… Read More

Scottish CMO makes US appointment

SYMBIOSIS Pharmaceutical Services has further strengthened its North American presence with the appointment of an experienced executive to support increased demand for its sterile filling services from biotech companies.The UK-based contract manufacturing organisation (CMO) has appointed Dr. Thomas Scullion as a US business development manager to aid the company’s growing commercial interests and client relationships in the US.The senior appointment has been… Read More

US biotechs driving growth at Scottish CMO

Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a significant surge in demand for its services from US-based biotechnology firms just a year after it expanded its presence into this territory.The fast-growing contract manufacturing organisation (CMO) has picked-up several new clients in North America, which has primarily been driven by companies looking for small scale aseptic manufacturing capabilities to… Read More

Sterile manufacturing specialists strengthens team

Sterile manufacturing expert Symbiosis Pharmaceutical Services has bolstered its project management and manufacturing teams with the appointment of several new staff to support its ongoing growth.The fast-growing contract manufacturing organisation (CMO) has increased employee numbers by around 35% over the last 18 months and expects this to continue in 2016 as the Scotland-based company continues to expand.Symbiosis specialises in the sterile fill/finish of… Read More

UK CMO APPOINTS NEW DIRECTOR

STERILE manufacturing specialist Symbiosis Pharmaceutical Services has appointed Joanne Anderson as its new Business Development Director to help drive its commercial growth.The company has promoted Mrs Anderson to the role following three successful years with the Scotland-based pharmaceutical contract manufacturing organisation (CMO) and will join the management team.Reporting to the CEO, her responsibilities will include the strategic and operational management of all… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.